Content about Manufacturing

LONDON Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in early- and mid-stage clinical trials, the two companies said Wednesday.

Lonza will manufacture clinical trial batches of the drugs, all monoclonal antibodies in phase-1 and phase-2 testing, and provide additional access to manufacturing capacity so GSK can fulfill future demands. The two companies said other details of the agreement remain confidential.

WHAT IT MEANS AND WHY IT'S IMPORTANT Procter & Gamble's plan to move toward sugarcane-based plastic packaging for some of its beauty brands marks the latest "green" movement by the company, and it is something the industry likely will see more of from manufacturers as the sustainable packaging industry is expected to see significant growth in the coming years.

(THE NEWS: P&G to roll out eco-friendly packaging for beauty brands. For the full story, click here)

MORRISTOWN, N.J. Actavis on Tuesday announced the reintroduction of its FeverAll acetaminophen suppositories to retail following the completion of updates to the company’s manufacturing facility.

The brand will be marketed in publications read by new parents and healthcare professionals, the company stated.

WHAT IT MEANS AND WHY IT'S IMPORTANT The dietary supplement industry is free at last from any major news organization making any kind of assertion that the industry is “unregulated.”

(THE NEWS: CRN: Dietary supplement manufacturers must be GMP-compliant. For the full story, click here)

FORT WASHINGTON, Pa. McNeil Consumer Healthcare once again is recalling certain lots of its products as it is probed by federal investigators for its recall of children’s cough-cold products and manufacturing plant closure.